-transparent.png){kind=logo}
The bioassay using the polythemic mice demonstrated persistent erythropoietin (Ep) activity in 24 renal carcinoma patients. Eight patients without clinical evidence of renal carcinoma had Ep levels that were slightly higher than those of controls, suggesting the possibility of occult disease. Increased levels of Ep were noted in 5 patients with other genitourinary carcinomas. This selective study reaffirms the value of Ep as a biologic marker in some renal cell cancers, and occasionally in other genitourinary tumors.
Related Publications
U O Nseyo, and
P D Williams, and
G P Murphy
January 2013,
BMC cancer,
U O Nseyo, and
P D Williams, and
G P Murphy
August 2007,
BJU international,
U O Nseyo, and
P D Williams, and
G P Murphy
May 1989,
Nihon Jinzo Gakkai shi,
U O Nseyo, and
P D Williams, and
G P Murphy
September 1992,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
U O Nseyo, and
P D Williams, and
G P Murphy
March 2015,
Oncology reports,
U O Nseyo, and
P D Williams, and
G P Murphy
March 1985,
Rinsho byori. The Japanese journal of clinical pathology,
U O Nseyo, and
P D Williams, and
G P Murphy
May 2012,
BMC cancer,
U O Nseyo, and
P D Williams, and
G P Murphy
May 2009,
Zhonghua wai ke za zhi [Chinese journal of surgery],
U O Nseyo, and
P D Williams, and
G P Murphy
January 1998,
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
U O Nseyo, and
P D Williams, and
G P Murphy
June 2007,
Cancer letters,
